{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T18:39:19Z","timestamp":1783708759010,"version":"3.55.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T00:00:00Z","timestamp":1729814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T00:00:00Z","timestamp":1729814400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br Dent J"],"published-print":{"date-parts":[[2024,10,25]]},"DOI":"10.1038\/s41415-024-7968-5","type":"journal-article","created":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T10:02:22Z","timestamp":1729850542000},"page":"645-651","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["An institutional protocol including socket alveoplasty and primary closure following dental extractions for patients with an elevated risk of developing medication-related osteonecrosis of the jaw"],"prefix":"10.1038","volume":"237","author":[{"given":"Richa","family":"Arya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Miles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Sproat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipesh","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,25]]},"reference":[{"key":"7968_CR6458","doi-asserted-by":"crossref","unstructured":"King R, Tanna N, Patel V. Medication-related osteonecrosis of the jaw unrelated to bisphosphonates and denosumab -a review. Oral Surg Oral Med Oral Pathol Oral Radiol 2019; 127: 289-299.","DOI":"10.1016\/j.oooo.2018.11.012"},{"key":"7968_CR6460","doi-asserted-by":"crossref","unstructured":"Ruggiero S L, Dodson T B, Aghaloo T, Carlson E R, Ward B B, Kademani D. American Association of Oral and Maxillofacial Surgeons' Position Paper on Medication-Related Osteonecrosis of the Jaws - 2022 Update. J Oral Maxillofac Surg 2022; 80: 920-943.","DOI":"10.1016\/j.joms.2022.02.008"},{"key":"7968_CR6463","unstructured":"UK Chemotherapy Board. Medication-related osteonecrosis of the jaw: guidance for the oncology multidisciplinary team. 2019. Available at https:\/\/www.rcplondon.ac.uk\/file\/16661\/download (accessed March 2023)."},{"key":"7968_CR6465","unstructured":"Scottish Dental Clinical Effectiveness Programme. Oral health management of patients at risk of medication-related osteonecrosis of the jaw. 2017. Available at https:\/\/www.sdcep.org.uk\/published-guidance\/medication-related-osteonecrosis-of-the-jaw\/ (accessed September 2024)."},{"key":"7968_CR6467","doi-asserted-by":"crossref","unstructured":"McGowan K, McGowan T, Ivanovski S. Risk factors for medication-related osteonecrosis of the jaws: a systematic review. Oral Dis 2018; 24: 527-536.","DOI":"10.1111\/odi.12708"},{"key":"7968_CR6469","doi-asserted-by":"crossref","unstructured":"Ristow O, R\u00fcckschlo\u03b2 T, Schnug G et al. Comparison of Different Antibiotic Regimes for Preventive Tooth Extractions in Patients with Antiresorptive Intake - A Retrospective Cohort Study. Antibiotics 2023; 12: 997.","DOI":"10.3390\/antibiotics12060997"},{"key":"7968_CR6471","doi-asserted-by":"crossref","unstructured":"Coropciuc R, Coopman R, Garip M et al. Risk of medication-related osteonecrosis of the jaw after dental extractions in patients receiving antiresorptive agents - a retrospective study of 240 patients. Bone 2023; 170: 116722.","DOI":"10.1016\/j.bone.2023.116722"},{"key":"7968_CR6474","doi-asserted-by":"crossref","unstructured":"Patel V, Grossman S, Wali R et al. The presenting dental status of solid tumours with bone metastases requiring bone-targeting agents - part 1: an overview. Br Dent J 2022; DOI: 10.1038\/s41415-021-3825-y.","DOI":"10.1038\/s41415-021-3825-y"},{"key":"7968_CR6476","doi-asserted-by":"crossref","unstructured":"Patel V, Wali R, Burns M et al. The presenting dental status of solid tumours with bone metastases requiring bone-targeting agents - part 2: breast cancer. Br Dent J 2022; 232: 95-100.","DOI":"10.1038\/s41415-022-3875-9"},{"key":"7968_CR6478","doi-asserted-by":"crossref","unstructured":"Patel V, Burns M, Patel S et al. The presenting dental status of solid tumours with bone metastases requiring bone-targeting agents - part 3: prostate cancer. Br Dent J 2022; DOI: 10.1038\/s41415-022-3928-0.","DOI":"10.1038\/s41415-022-3928-0"},{"key":"7968_CR6480","doi-asserted-by":"crossref","unstructured":"Patel V, Patel S, Grossman S et al. The presenting dental status of solid tumours with bone metastases requiring bone-targeting agents - part 4: miscellaneous cancers. Br Dent J 2022; 232: 213-218.","DOI":"10.1038\/s41415-022-3983-6"},{"key":"7968_CR6483","doi-asserted-by":"crossref","unstructured":"Fernandes U, Guidi G, Martins D et al. Breast cancer in young women: a rising threat: a 5-year follow-up comparative study. Porto Biomed J 2023; 8: e213.","DOI":"10.1097\/j.pbj.0000000000000213"},{"key":"7968_CR6485","doi-asserted-by":"crossref","unstructured":"Liu C, Xiong Y-T, Zhu T, Liu W, Tang W, Zeng W. Management of Tooth Extraction in Patients Taking Antiresorptive Drugs: An Evidence Mapping Review and Meta-Analysis. J Clin Med 2022; 12: 239.","DOI":"10.3390\/jcm12010239"},{"key":"7968_CR6487","doi-asserted-by":"crossref","unstructured":"Ottesen C, Schiodt M, Gotfredsen K. Efficacy of a high-dose antiresorptive drug holiday to reduce the risk of medication-related osteonecrosis of the jaw (MRONJ): a systematic review. Heliyon 2020; 6: e03795.","DOI":"10.1016\/j.heliyon.2020.e03795"},{"key":"7968_CR6490","doi-asserted-by":"crossref","unstructured":"Miranda M, Gianfreda F, Raffone C, Antonacci D, Pistilli V, Bollero P. The Role of Platelet-Rich Fibrin (PRF) in the Prevention of Medication-Related Osteonecrosis of the Jaw (MRONJ). Biomed Res Int 2021; 2021: 4948139.","DOI":"10.1155\/2021\/4948139"},{"key":"7968_CR6492","doi-asserted-by":"crossref","unstructured":"Nowak S M, Sacco R, Mitchell F L, Patel V, Gurzawska-Comis K. The effectiveness of autologous platelet concentrates in prevention and treatment of medication-related osteonecrosis of the jaws: a systematic review. J Craniomaxillofac Surg 2024; 52: 672-691.","DOI":"10.1016\/j.jcms.2024.01.007"},{"key":"7968_CR6494","doi-asserted-by":"crossref","unstructured":"Vescovi P, Giovannacci I, Merigo E et al. Tooth extractions in high-risk patients under bisphosphonate therapy and previously affected with osteonecrosis of the jaws: surgical protocol supported by low-level laser therapy. J Craniofac Surg 2015; 26: 696-699.","DOI":"10.1097\/SCS.0000000000001665"},{"key":"7968_CR6496","unstructured":"Schiodt M. When and How to Extract Teeth under Antiresorptive Treatment - Guidelines for the Dental Practitioner in Denmark. In Proceedings of the 3rd International Symposium on Medication Related Osteonecrosis of the Jaw (MRONJ). Denmark, 15 November 2019."},{"key":"7968_CR6498","doi-asserted-by":"crossref","unstructured":"Mauceri R, Coniglio R, Abbinante A et al. The preventive care of medication-related osteonecrosis of the jaw (MRONJ): a position paper by Italian experts for dental hygienists. Support Care Cancer 2022; 30: 6429-6440.","DOI":"10.1007\/s00520-022-06940-8"},{"key":"7968_CR6501","unstructured":"AWMF Online. S3 guideline on antiresorptive-associated osteonecrosis of the jaw (AR-ONJ). 2018. Available at www.awmf.org (accessed May 2023)."},{"key":"7968_CR6505","doi-asserted-by":"crossref","unstructured":"Schwech N, Nilsson J, Gabre P. Incidence and risk factors for medication-related osteonecrosis after tooth extraction in cancer patients - a systematic review. Clin Exp Dent Res 2023; 9: 55-65.","DOI":"10.1002\/cre2.698"},{"key":"7968_CR6507","doi-asserted-by":"crossref","unstructured":"Cabras M, Gambino A, Broccoletti R, Sciascia S, Arduino P G. Lack of evidence in reducing risk of MRONJ after teeth extractions with systemic antibiotics. J Oral Sci 2021; 63: 217-226.","DOI":"10.2334\/josnusd.21-0016"},{"key":"7968_CR6509","doi-asserted-by":"crossref","unstructured":"Ferlito S, Puzzo S, Liardo C. Preventive protocol for tooth extractions in patients treated with zoledronate: a case series. J Oral Maxillofac Surg 2011; 69: 1-4.","DOI":"10.1016\/j.joms.2010.10.055"},{"key":"7968_CR6512","doi-asserted-by":"crossref","unstructured":"Kyrgidis A, Vahtsevanos K, Koloutsos G et al. Bisphosphonate-related osteonecrosis of the jaws: a case-control study of risk factors in breast cancer patients. J Clin Oncol 2008; 26: 4634-4638.","DOI":"10.1200\/JCO.2008.16.2768"},{"key":"7968_CR6514","doi-asserted-by":"crossref","unstructured":"Otto S, Aljohani S, Fliefel R et al. Infection as an Important Factor in Medication-Related Osteonecrosis of the Jaw (MRONJ). Medicina 2021; 57: 463.","DOI":"10.3390\/medicina57050463"},{"key":"7968_CR6516","unstructured":"Spanou A, Nelson K, Ermer M A, Steybe D, Poxleitner P, Voss P J. Primary wound closure and perioperative antibiotic therapy for prevention of bisphosphonate-related osteonecrosis of the jaw after tooth extraction. Quintessence Int 2020; 51: 220-228."},{"key":"7968_CR6518","doi-asserted-by":"crossref","unstructured":"Otto S, Pautke C, Van den Wyngaert T, Niepel D, Schi\u00f8dt M. Medication-related osteonecrosis of the jaw: Prevention, diagnosis and management in patients with cancer and bone metastases. Cancer Treat Rev 2018; 69: 177-187.","DOI":"10.1016\/j.ctrv.2018.06.007"},{"key":"7968_CR6521","doi-asserted-by":"crossref","unstructured":"Abtahi J, Agholme F, Aspenberg P. Prevention of osteonecrosis of the jaw by mucoperiosteal coverage in a rat model. Int J Oral Maxillofac Surg 2013; 42: 632-636.","DOI":"10.1016\/j.ijom.2013.02.007"},{"key":"7968_CR6523","doi-asserted-by":"crossref","unstructured":"Ristow O, R\u00fcckschlo\u03b2 T, Moratin J et al. Wound closure and alveoplasty after preventive tooth extractions in patients with antiresorptive intake - a randomized pilot trial. Oral Dis 2021; 27: 532-546.","DOI":"10.1111\/odi.13556"},{"key":"7968_CR6525","doi-asserted-by":"crossref","unstructured":"Lodi G, Sardella A, Salis A, Demarosi F, Tarozzi M, Carrassi A. Tooth extraction in patients taking intravenous bisphosphonates: a preventive protocol and case series. J Oral Maxillofac Surg 2010; 68: 107-110.","DOI":"10.1016\/j.joms.2009.07.068"},{"key":"7968_CR6528","doi-asserted-by":"crossref","unstructured":"Otto S, Tr\u00f6ltzsch M, Jambrovic V et al. Tooth extraction in patients receiving oral or intravenous bisphosphonate administration: a trigger for BRONJ development? J Craniomaxillofac Surg 2015; 43: 847-854.","DOI":"10.1016\/j.jcms.2015.03.039"},{"key":"7968_CR6531","doi-asserted-by":"crossref","unstructured":"Soutome S, Otsuru M, Murata M et al. Risk factors for developing medication-related osteonecrosis of the jaw when preserving the tooth that can be a source of infection in cancer patients receiving high-dose antiresorptive agents: a retrospective study. Support Care Cancer 2022; 30: 7241-7248.","DOI":"10.1007\/s00520-022-07134-y"},{"key":"7968_CR6533","doi-asserted-by":"crossref","unstructured":"Sedghizadeh P P, Kumar S K, Gorur A, Schaudinn C, Shuler C F, Costerton J W. Microbial biofilms in osteomyelitis of the jaw and osteonecrosis of the jaw secondary to bisphosphonate therapy. J Am Dent Assoc 2009; 140: 1259-1265.","DOI":"10.14219\/jada.archive.2009.0049"},{"key":"7968_CR6535","doi-asserted-by":"crossref","unstructured":"Matsumoto A, Sasaki M, Schmelzeisen R, Oyama Y, Mori Y, Voss P J. Primary wound closure after tooth extraction for prevention of medication-related osteonecrosis of the jaw in patients under denosumab. Clin Oral Investig 2017; 21: 127-134.","DOI":"10.1007\/s00784-016-1762-y"},{"key":"7968_CR6537","unstructured":"Ga\u00eata-Araujo H, Ferreira Leite A, de Faria Vasconcelos K et al. Why do some extraction sites develop medication-related osteonecrosis of the jaw and others do not? A within-patient study assessing radiographic predictors. Int J Oral Implantol 2021; 14: 87-98."},{"key":"7968_CR6540","doi-asserted-by":"crossref","unstructured":"Nicolatou-Galitis O, Papadopoulou E, Vardas E et al. Alveolar bone histological necrosis observed prior to extractions in patients, who received bone-targeting agents Oral Dis 2020; 26: 955-966.","DOI":"10.1111\/odi.13294"},{"key":"7968_CR6542","doi-asserted-by":"crossref","unstructured":"Saia G, Blandamura S, Bettini G et al. Occurrence of bisphosphonate-related osteonecrosis of the jaw after surgical tooth extraction. J Oral Maxillofac Surg 2010; 68: 797-804.","DOI":"10.1016\/j.joms.2009.10.026"},{"key":"7968_CR6544","doi-asserted-by":"crossref","unstructured":"Bedogni A, Blandamura S, Lokmic Z et al. Bisphosphonate-associated jawbone osteonecrosis: a correlation between imaging techniques and histopathology. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008; 105: 358-364.","DOI":"10.1016\/j.tripleo.2007.08.040"},{"key":"7968_CR6546","doi-asserted-by":"crossref","unstructured":"Shimamoto H, Grogan T R, Tsujimoto T et al. Does CBCT alter the diagnostic thinking efficacy, management and prognosis of patients with suspected Stage 0 medication-related osteonecrosis of the jaws? Dentomaxillofac Radiol 2018; 47: 20170290.","DOI":"10.1259\/dmfr.20170290"},{"key":"7968_CR6549","doi-asserted-by":"crossref","unstructured":"Al-Sarraj M, Burns M, Patel V. Pre-existing medication related osteonecrosis of the jaw before dental extraction. Br Dent J 2023; 235: 783-788.","DOI":"10.1038\/s41415-023-6447-8"},{"key":"7968_CR6552","doi-asserted-by":"crossref","unstructured":"Moreno-Rabi\u00e9 C, Lapauw L, Ga\u00eata-Araujo H et al. Radiographic predictors for MRONJ in oncologic patients undergoing tooth extraction. Sci Rep 2022; 12: 11280.","DOI":"10.1038\/s41598-022-15254-y"},{"key":"7968_CR6554","doi-asserted-by":"crossref","unstructured":"King R, Zebic L, Patel V. Deciphering novel chemotherapy and its impact on dentistry. Br Dent J 2020; 228: 415-421.","DOI":"10.1038\/s41415-020-1365-5"},{"key":"7968_CR6556","doi-asserted-by":"crossref","unstructured":"Zebic L, Patel V. Preventing medication-related osteonecrosis of the jaw. BMJ 2019; 365: 1733.","DOI":"10.1136\/bmj.l1733"},{"key":"7968_CR6559","doi-asserted-by":"crossref","unstructured":"Poxleitner P, Ermer M A, Trittler R et al. Concentration of Penicillin G in Jawbone Affected by Antiresorptive Agent-Related Osteonecrosis following a Single Preoperative Dose. Antibiotics 2020; 10: 17.","DOI":"10.3390\/antibiotics10010017"},{"key":"7968_CR6561","doi-asserted-by":"crossref","unstructured":"Montefusco V, Gay F, Spina F et al. Antibiotic prophylaxis before dental procedures may reduce the incidence of osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates. Leuk Lymphoma 2008; 49: 2156-2162.","DOI":"10.1080\/10428190802483778"},{"key":"7968_CR6563","doi-asserted-by":"crossref","unstructured":"Colella A, Yu E, Sambrook P, Hughes T, Goss A. What is the Risk of Developing Osteonecrosis Following Dental Extractions for Patients on Denosumab for Osteoporosis? J Oral Maxillofac Surg 2023; 81: 232-237.","DOI":"10.1016\/j.joms.2022.10.014"},{"key":"7968_CR6566","doi-asserted-by":"crossref","unstructured":"Otto S, Abu-Id M H, Fedele S et al. Osteoporosis and bisphosphonates-related osteonecrosis of the jaw: not just a sporadic coincidence - a multi-centre study. J Craniomaxillofac Surg 2011; 39: 272-277.","DOI":"10.1016\/j.jcms.2010.05.009"},{"key":"7968_CR6568","doi-asserted-by":"crossref","unstructured":"Ng T L, Tu M M, Ibrahim M F K et al. Long-term impact of bone-modifying agents for the treatment of bone metastases: a systematic review. Support Care Cancer 2021; 29: 925-943.","DOI":"10.1007\/s00520-020-05556-0"},{"key":"7968_CR6570","doi-asserted-by":"crossref","unstructured":"Rosella D, Papi P, Giardino R, Cicalini E, Piccoli L, Pompa G. Medication-related osteonecrosis of the jaw: clinical and practical guidelines. J Int Soc Prev Community Dent 2016; 6: 97-104.","DOI":"10.4103\/2231-0762.178742"},{"key":"7968_CR6572","doi-asserted-by":"crossref","unstructured":"Kuroshima S, Sasaki M, Sawase T. Medication-related osteonecrosis of the jaw: a literature review. J Oral Biosci 2019; 61: 99-104.","DOI":"10.1016\/j.job.2019.03.005"},{"key":"7968_CR6576","doi-asserted-by":"crossref","unstructured":"Ruggiero S L, Fantasia J, Carlson E. Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006; 102: 433-441.","DOI":"10.1016\/j.tripleo.2006.06.004"},{"key":"7968_CR6578","doi-asserted-by":"crossref","unstructured":"Patel V, Mansi J, Ghosh S et al. MRONJ risk of adjuvant bisphosphonates in early stage breast cancer. Br Dent J 2018; 224: 74-79.","DOI":"10.1038\/sj.bdj.2017.1039"}],"container-title":["British Dental Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41415-024-7968-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41415-024-7968-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41415-024-7968-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T10:06:43Z","timestamp":1729850803000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41415-024-7968-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,25]]},"references-count":52,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,10,25]]}},"alternative-id":["7968"],"URL":"https:\/\/doi.org\/10.1038\/s41415-024-7968-5","relation":{},"ISSN":["0007-0610","1476-5373"],"issn-type":[{"value":"0007-0610","type":"print"},{"value":"1476-5373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,25]]},"assertion":[{"value":"6 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declaration"}},{"value":"Ethics approval was not applicable as this is a retrospective clinical evaluation of departmental standard operating procedure clinical practice and not a research study. Consent was not required for retrospective data collection from clinical records.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declaration"}}]}}